Rapacz A, Jakubiec M, Abram M, Jasinski J, Chrzan K, Gora M
Pharmaceuticals (Basel). 2024; 17(11).
PMID: 39598442
PMC: 11597642.
DOI: 10.3390/ph17111532.
Elsheikh S, Coles N, Achadu O, Filippou P, Khundakar A
Biosensors (Basel). 2024; 14(1).
PMID: 38248410
PMC: 10813143.
DOI: 10.3390/bios14010033.
Loscher W, White H
Cells. 2023; 12(9).
PMID: 37174633
PMC: 10177106.
DOI: 10.3390/cells12091233.
Prentice R, Rizwan S
Pharmaceutics. 2023; 15(1).
PMID: 36678862
PMC: 9865314.
DOI: 10.3390/pharmaceutics15010233.
Waszkielewicz A, Marona H, Panczyk-Straszak K, Filipek B, Rapacz A, Salat K
Pharmacol Rep. 2022; 75(1):128-165.
PMID: 36401763
PMC: 9889419.
DOI: 10.1007/s43440-022-00431-7.
A Concise Total Synthesis of the Fungal Isoquinoline Alkaloid TMC-120B.
Haidar A, Kjeldsen N, Troelsen N, Previtali V, Lundquist K, Larsen T
Molecules. 2022; 27(2).
PMID: 35056832
PMC: 8779217.
DOI: 10.3390/molecules27020521.
Hippocampal BMP signaling as a common pathway for antidepressant action.
Tunc-Ozcan E, Brooker S, Bonds J, Tsai Y, Rawat R, McGuire T
Cell Mol Life Sci. 2021; 79(1):31.
PMID: 34936033
PMC: 8740160.
DOI: 10.1007/s00018-021-04026-y.
Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options.
Loscher W, Potschka H, Sisodiya S, Vezzani A
Pharmacol Rev. 2020; 72(3):606-638.
PMID: 32540959
PMC: 7300324.
DOI: 10.1124/pr.120.019539.
Optogenetically-Induced Population Discharge Threshold as a Sensitive Measure of Network Excitability.
Klorig D, Alberto G, Smith T, Godwin D
eNeuro. 2019; 6(6).
PMID: 31619450
PMC: 6838688.
DOI: 10.1523/ENEURO.0229-18.2019.
The 4-Aminopyridine Model of Acute Seizures Elucidates Efficacy of New Antiepileptic Drugs.
Heuzeroth H, Wawra M, Fidzinski P, Dag R, Holtkamp M
Front Neurosci. 2019; 13:677.
PMID: 31316344
PMC: 6610309.
DOI: 10.3389/fnins.2019.00677.
A companion to the preclinical common data elements for pharmacologic studies in animal models of seizures and epilepsy. A Report of the TASK3 Pharmacology Working Group of the ILAE/AES Joint Translational Task Force.
Barker-Haliski M, Harte-Hargrove L, Ravizza T, Smolders I, Xiao B, Brandt C
Epilepsia Open. 2018; 3(Suppl Suppl 1):53-68.
PMID: 30450485
PMC: 6210039.
DOI: 10.1002/epi4.12254.
Pharmacotherapy for Refractory and Super-Refractory Status Epilepticus in Adults.
Holtkamp M
Drugs. 2018; 78(3):307-326.
PMID: 29368126
DOI: 10.1007/s40265-017-0859-1.
Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP).
Klein B, Jacobson C, Metcalf C, Smith M, Wilcox K, Hampson A
Neurochem Res. 2017; 42(7):1939-1948.
PMID: 28478594
DOI: 10.1007/s11064-017-2287-8.
Development and pharmacologic characterization of the rat 6 Hz model of partial seizures.
Metcalf C, West P, Thomson K, Edwards S, Smith M, White H
Epilepsia. 2017; 58(6):1073-1084.
PMID: 28449218
PMC: 5469205.
DOI: 10.1111/epi.13764.
Achyranthes aspera Attenuates epilepsy in experimental animals: possible involvement of GABAergic mechanism.
Viswanatha G, Venkataranganna M, Prasad N, Godavarthi A
Metab Brain Dis. 2017; 32(3):867-879.
PMID: 28265839
DOI: 10.1007/s11011-017-9981-8.
SCN3A deficiency associated with increased seizure susceptibility.
Lamar T, Vanoye C, Calhoun J, Wong J, Dutton S, Jorge B
Neurobiol Dis. 2017; 102:38-48.
PMID: 28235671
PMC: 5446790.
DOI: 10.1016/j.nbd.2017.02.006.
Analgesic, antiallodynic, and anticonvulsant activity of novel hybrid molecules derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide in animal models of pain and epilepsy.
Rapacz A, Kaminski K, Obniska J, Koczurkiewicz P, Pekala E, Filipek B
Naunyn Schmiedebergs Arch Pharmacol. 2017; 390(6):567-579.
PMID: 28188357
PMC: 5411412.
DOI: 10.1007/s00210-017-1358-3.
Progressive Seizure Aggravation in the Repeated 6-Hz Corneal Stimulation Model Is Accompanied by Marked Increase in Hippocampal p-ERK1/2 Immunoreactivity in Neurons.
Giordano C, Costa A, Lucchi C, Leo G, Brunel L, Fehrentz J
Front Cell Neurosci. 2016; 10:281.
PMID: 28018175
PMC: 5159434.
DOI: 10.3389/fncel.2016.00281.
Huperzine A Provides Robust and Sustained Protection against Induced Seizures in Mutant Mice.
Wong J, Dutton S, Collins S, Schachter S, Escayg A
Front Pharmacol. 2016; 7:357.
PMID: 27799911
PMC: 5065986.
DOI: 10.3389/fphar.2016.00357.
Cytisine inhibits the protective activity of various classical and novel antiepileptic drugs against 6 Hz-induced psychomotor seizures in mice.
Tutka P, Kondrat-Wrobel M, Zaluska K, Zolkowska D, Florek-Luszczki M, Luszczki J
Psychopharmacology (Berl). 2016; 234(2):281-291.
PMID: 27778062
DOI: 10.1007/s00213-016-4461-0.
